Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AVGR

Avinger (AVGR) Stock Price, News & Analysis

Avinger logo

About Avinger Stock (NASDAQ:AVGR)

Key Stats

Today's Range
$0.47
▼
$0.47
50-Day Range
$0.47
▼
$0.47
52-Week Range
$0.36
▼
$1.93
Volume
N/A
Average Volume
1.46 million shs
Market Capitalization
$1.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVGR Stock News Headlines

Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
See More Headlines

AVGR Stock Analysis - Frequently Asked Questions

Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings data on Thursday, November, 7th. The medical device company reported ($1.82) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.03) by $0.21. The medical device company had revenue of $1.65 million for the quarter, compared to analysts' expectations of $1.60 million.
Read the conference call transcript
.

Shares of Avinger reverse split on the morning of Wednesday, September 13th 2023.The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Avinger (AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avinger investors own include Bionano Genomics (BNGO), Jaguar Animal Health (JAGX), BIOLASE (BIOL), Purple Biotech (PPBT), Oragenics (OGEN), Ayala Pharmaceuticals (ADXS) and Senseonics Holdings, Inc. Common Stock (SENS).

Company Calendar

Last Earnings
11/07/2024
Today
10/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:AVGR
CIK
1506928
Employees
70
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$7.65 million
Price / Sales
0.21
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($4.53) per share
Price / Book
-0.10

Miscellaneous

Outstanding Shares
3,310,000
Free Float
1,893,000
Market Cap
$1.57 million
Optionable
Not Optionable
Beta
1.29

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:AVGR) was last updated on 4/8/2026 by MarketBeat.com Staff.
From Our Partners